Table of Contents Author Guidelines Submit a Manuscript
Critical Care Research and Practice
Volume 2010, Article ID 235894, 5 pages
http://dx.doi.org/10.1155/2010/235894
Clinical Study

Prophylactic Administration of Surfactant in Extremely Premature Infants

Division of Neonatology, Department of Pediatrics, University of Heidelberg Medical School, Im Neuenheimer Feld 430, 69120 Heidelberg, Germany

Received 26 August 2009; Revised 21 January 2010; Accepted 24 March 2010

Academic Editor: Ira Cheifetz

Copyright © 2010 Lutz Koch et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. F. Soll and C. J. Morley, “Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD000510, 2001. View at Google Scholar
  2. H. L. Halliday, “Recent clinical trials of surfactant treatment for neonates,” Biology of the Neonate, vol. 89, no. 4, pp. 323–329, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. A. Ammari, M. Suri, V. Milisavljevic et al., “Variables associated with the early failure of nasal CPAP in very low birth weight infants,” Journal of Pediatrics, vol. 147, no. 3, pp. 341–347, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. N. N. Finer, W. A. Carlo, S. Duara et al., “Delivery room continuous positive airway pressure/positive end-expiratory pressure in extremely low birth weight infants: a feasibility trial,” Pediatrics, vol. 114, no. 3, pp. 651–657, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. M. Sperandio, B. Beedgen, R. Feneberg et al., “Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation,” Pediatrics, vol. 116, no. 6, pp. 1361–1366, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. P. Gastmeier, C. Geffers, F. Schwab, J. Fitzner, M. Obladen, and H. Ruden, “Development of a surveillance system for nosocomial infections: the component for neonatal intensive care units in Germany,” Journal of Hospital Infection, vol. 57, no. 2, pp. 126–131, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. T. P. Stevens, E. W. Harrington, M. Blennow, and R. F. Soll, “Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome,” Cochrane Database of Systematic Reviews, no. 4, Article ID CD003063, 2007. View at Google Scholar
  8. R. Ramanathan, “Optimal ventilatory strategies and surfactant to protect the preterm lungs,” Neonatology, vol. 93, no. 4, pp. 302–308, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. J. D. Horbar, J. H. Carpenter, J. Buzas et al., “Timing of initial surfactant treatment for infants 23 to 29 weeks' gestation: is routine practice evidence based?” Pediatrics, vol. 113, no. 6, pp. 1593–1602, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Sweet, G. Bevilacqua, V. Carnielli et al., “European consensus guidelines on the management of neonatal respiratory distress syndrome,” Journal of Perinatal Medicine, vol. 35, no. 3, pp. 175–186, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. J. W. Kendig, R. H. Notter, D. C. Cox et al., “A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation,” New England Journal of Medicine, vol. 324, no. 13, pp. 865–871, 1991. View at Google Scholar · View at Scopus
  12. J. Egberts, R. Brand, H. Walti, G. Bevilacqua, G. Bréart, and F. Gardini, “Mortality, severe respiratory distress syndrome, and chronic lung disease of the newborn are reduced more after prophylactic than after therapeutic administration of the surfactant Curosurf,” Pediatrics, vol. 100, no. 1, p. E4, 1997. View at Google Scholar
  13. G. Bevilacqua, S. Parmigiani, B. Robertson et al., “Prophylaxis of respiratory distress syndrome by treatment with modified porcine surfactant at birth: a multicentre prospective randomized trial,” Journal of Perinatal Medicine, vol. 24, no. 6, pp. 609–620, 1996. View at Google Scholar · View at Scopus
  14. M. J. Kresch and J. M. Clive, “Meta-analyses of surfactant replacement therapy of infants with birth weights less than 2000 grams,” Journal of Perinatology, vol. 18, no. 4, pp. 276–283, 1998. View at Google Scholar · View at Scopus
  15. A. Reininger, R. Khalak, J. W. Kendig et al., “Surfactant administration by transient intubation in infants 29 to 35 weeks' gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: a randomized controlled trial,” Journal of Perinatology, vol. 25, no. 11, pp. 703–708, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. M. A. Thomson, “Continuous positive airway pressure and surfactant; combined data from animal experiments and clinical trials,” Biology of the Neonate, vol. 81, supplement 1, pp. 16–19, 2002. View at Google Scholar · View at Scopus
  17. C. J. Morley, P. G. Davis, L. W. Doyle, L. P. Brion, J.-M. Hascoet, and J. B. Carlin, “Nasal CPAP or intubation at birth for very preterm infants,” New England Journal of Medicine, vol. 358, no. 7, pp. 700–708, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. F. Sandri, G. Ancora, A. Lanzoni et al., “Prophylactic nasal continuous positive airways pressure in newborn of 28–31 weeks gestation: multicentre randomised controlled clinical trial,” Archives of Disease in Childhood, vol. 89, no. 5, pp. F394–F398, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. H. Verder, P. Albertsen, F. Ebbesen et al., “Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation,” Pediatrics, vol. 103, no. 2, p. E24, 1999. View at Google Scholar
  20. H. Verder, B. Robertson, G. Greisen et al., “Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group,” New England Journal of Medicine, vol. 331, no. 16, pp. 1051–1055, 1994. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Ikegami, H. Jacobs, and A. Jobe, “Surfactant function in respiratory distress syndrome,” Journal of Pediatrics, vol. 102, no. 3, pp. 443–447, 1983. View at Google Scholar · View at Scopus
  22. A. Jobe, M. Ikegami, H. Jacobs, S. Jones, and D. Conaway, “Permeability of premature lamb lungs to protein and the effect of surfactant on that permeability,” Journal of Applied Physiology, vol. 55, no. 1, pp. 169–176, 1983. View at Google Scholar · View at Scopus
  23. M. Ikegami, A. H. Jobe, S. Seidner, and T. Yamada, “Gestational effects of corticosteroids and surfactant in ventilated rabbits,” Pediatric Research, vol. 25, no. 1, pp. 32–37, 1989. View at Google Scholar · View at Scopus
  24. G. Grossmann, R. Nilsson, and B. Robertson, “Scanning electron microscopy of epithelial lesions induced by artificial ventilation of the immature neonatal lung: the prophylactic effect of surfactant replacement,” European Journal of Pediatrics, vol. 145, no. 5, pp. 361–367, 1986. View at Google Scholar · View at Scopus
  25. T. A. Merritt, M. Hallman, K. Holcomb et al., “Human surfactant treatment of severe respiratory distress syndrome: pulmonary effluent indicators of lung inflammation,” Journal of Pediatrics, vol. 108, no. 5 I, pp. 741–748, 1986. View at Google Scholar · View at Scopus
  26. “Surfactant positive airway pressure and pulse oximetry trial (SUPPORT),” http://clinicaltrials.gov/ct2/show/NCT00233324.
  27. F. Sandri, R. Plavka, and U. Simeoni, “The CURPAP study: an international randomized controlled trial to evaluate the efficacy of combining prophylactic surfactant and early nasal continuous positive airway pressure in very preterm infants,” Neonatology, vol. 94, no. 1, pp. 60–62, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus